Publications
5891 Results
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr 4023); American Society of Clinical Oncology 2011 meeting, poster discussion;
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0356
Association of excision repair cross- comple-mentation Group 1 (ERCC1) gene expression (GE) with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative group study (SWOG S0356)
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl; abstr TPS101); ASCO Annual 2011 Meeting, poster presentation.
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S1007
Incorporating comparative effectiveness research study endpoints into the treatment for positive node, endocrine responsive breast cancer (RxPonder) study
- Journal / Conference
- J Thorac Oncol. 2011; 6(6)(suppl 2): S464. abstract 042.03; IASLC, 14th World Conference on Lung Cancer, oral presentation;
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/E1505
Interim report of on-study demographics and toxicity from Eastern Cooperative Oncology Group (ECOG) E1505, a phase III randomized trial of adjuvant chemotherapy with or without bevacizumab for completely resected early stage non-small cell lung cancer (NSCLC)
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl;abstr 3542); American Society of Clinical Oncology Annual Meeting, general poster;
- Year
- 2011
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9304 (INT-0144)
The final results of the SWOG S9304 phase III intergroup trial's pharmacogenetic analysis: association of polymorphisms with survival and toxicity in stage II/III rectal cancer patients treated with 5-fluorouracil (5-FU) and pelvic radiation (RT)
- Journal / Conference
- American Journal of Epidemiology 173(12):1419-1428
- Year
- 2011
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the Prostate Cancer Prevention Trial. PMID21540324
- Journal / Conference
- Journal of Clinical Oncology 29(16):2282-2290
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- C9741
Cancer and Leukemia Group B pathology committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues [PMID21519016; PMC3107745]
- Journal / Conference
- Proc CTOS 2011:24, 2011 (abstr 105) Connective Tissue Oncology Society Annual Meeting , oral
- Year
- 2011
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Long-term follow-up of SWOG S0033, a phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors (GIST)
- Journal / Conference
- Proc ESMO 47:S664 2011 (abstr 9404) (European Society for Medical Oncology Annual Meeting, oral)
- Year
- 2011
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S0033
Long-term survival on S0033: a phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTs)
- Journal / Conference
- Journal of Clinical Oncology 29(3):272-278
- Year
- 2011
- Research Committee(s)
- Lung
Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214 [PMID21135270; PMC3056462]
- Journal / Conference
- Journal of Clinical Oncology 29(3):279-286
- Year
- 2011
- Research Committee(s)
- Lung